Concordia International Corp Company Profile (TSE:CXR)

About Concordia International Corp (TSE:CXR)

Concordia International Corp logoConcordia International Corp, formerly Concordia Healthcare Corp, is a Canada-based pharmaceutical company. The Company, through subsidiaries, owns a portfolio of branded and generic prescription products. Its activities are divided into four segments: Concordia North America, includes sales of pharmaceutical products, such as Donnatal for the treatment of irritable bowel syndrome, Zonegran for the treatment of partial seizures in adults with epilepsy and Nilandron for the treatment of metastatic prostate cancer; Concordia International, includes a portfolio of branded and generic products that are sold to wholesalers, hospitals and pharmacies in over 100 countries, and focuses on acquisition, licensing and development of off-patent prescription medicines; Orphan Drugs, includes Photofrin, which is for the treatment of certain forms of rare cancer, and Corporate cost centre, includes centralized costs incurred by the Company.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: TSE:CXR
  • CUSIP: N/A
  • Web: N/A
  • Market Cap: C$90.94 million
  • Outstanding Shares: 51,089,000
Average Prices:
  • 50 Day Moving Avg: C$1.89
  • 200 Day Moving Avg: C$2.73
  • 52 Week Range: C$1.70 - C$28.35
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: C$748.18 million
  • Price / Sales: 0.12
  • Book Value: C($8.59) per share
  • Price / Book: -0.21
  • EBIDTA: C$380.7 million
  • Average Volume: 329,185 shs.
  • Short Ratio: 0.8

Frequently Asked Questions for Concordia International Corp (TSE:CXR)

What is Concordia International Corp's stock symbol?

Concordia International Corp trades on the Tornton Stock Exchange (TSX) under the ticker symbol "CXR."

How often does Concordia International Corp pay dividends? What is the dividend yield for Concordia International Corp?

Concordia International Corp announced a quarterly dividend on Wednesday, July 13th. Shareholders of record on Friday, July 29th will be given a dividend of 0.075 per share on Friday, July 29th. This represents a $0.30 dividend on an annualized basis and a dividend yield of 16.85%. The ex-dividend date of this dividend is Wednesday, July 13th. View Concordia International Corp's Dividend History.

How were Concordia International Corp's earnings last quarter?

Concordia International Corp (TSE:CXR) released its quarterly earnings data on Thursday, August, 13th. The company reported $1.04 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $1.06 by $0.02. The firm had revenue of $95.34 million for the quarter, compared to the consensus estimate of $87.41 million. View Concordia International Corp's Earnings History.

Where is Concordia International Corp's stock going? Where will Concordia International Corp's stock price be in 2017?

6 brokerages have issued 12-month price objectives for Concordia International Corp's shares. Their predictions range from C$13.50 to C$17.00. On average, they expect Concordia International Corp's share price to reach C$14.83 in the next twelve months. View Analyst Ratings for Concordia International Corp.

Who are some of Concordia International Corp's key competitors?

How do I buy Concordia International Corp stock?

Shares of Concordia International Corp and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

How much does a share of Concordia International Corp stock cost?

One share of Concordia International Corp stock can currently be purchased for approximately C$1.78.

Analyst Ratings

Consensus Ratings for Concordia International Corp (TSE:CXR) (?)
Ratings Breakdown: 5 Sell Ratings, 1 Hold Rating
Consensus Rating:Sell (Score: 1.17)
Consensus Price Target: C$14.83

Analysts' Ratings History for Concordia International Corp (TSE:CXR)
DateFirmActionRatingPrice TargetDetails
3/16/2017ScotiabankReiterated RatingUnderperformView Rating Details
2/9/2017TD SecuritiesDowngradeHold -> ReduceView Rating Details
12/8/2016Royal Bank of CanadaDowngradeSector Perform -> UnderperformView Rating Details
11/7/2016Bloom BurtonDowngradeHold -> SellView Rating Details
8/15/2016Goldman Sachs Group IncLower Price TargetC$34.00 -> C$17.00View Rating Details
8/15/2016CIBCDowngradeSector Perform -> UnderperformView Rating Details
3/21/2016Dundee SecuritiesLower Price TargetC$62.00 -> C$60.00View Rating Details
12/3/2015MackieDowngradeHoldView Rating Details
9/9/2015Canaccord GenuityBoost Price TargetC$95.00 -> C$100.00View Rating Details
(Data available from 5/25/2015 forward)


Earnings History for Concordia International Corp (TSE:CXR)
Earnings by Quarter for Concordia International Corp (TSE:CXR)
Earnings History by Quarter for Concordia International Corp (TSE:CXR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/13/2015Q2$1.06$1.04$87.41 million$95.34 millionViewListenView Earnings Details
8/13/2014$0.19($0.03)$24.42 million$28.49 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Concordia International Corp (TSE:CXR)
Current Year EPS Consensus Estimate: $1.26 EPS


Dividend History by Quarter for Concordia International Corp (TSE:CXR)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Concordia International Corp (TSE:CXR)
Insider Trades by Quarter for Concordia International Corp (TSE:CXR)
Insider Trades by Quarter for Concordia International Corp (TSE:CXR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/16/2017Graeme Neville DuncanDirectorSell7,065C$1.91C$13,494.15
2/1/2016Mark Laurence ThompsonDirectorBuy60C$28.77C$1,726.20
11/17/2015Rochelle FuhrmannDirectorBuy2,000C$31.67C$63,340.00
11/17/2015Wayne Walter KreppnerInsiderBuy3,000C$43.67C$131,010.00
11/16/2015Mark Laurence ThompsonDirectorBuy23,150C$43.36C$1,003,702.98
10/27/2015Edward BorkowskiDirectorBuy4,000C$30.43C$121,720.00
7/23/2015Jordan KupinskyDirectorSell43,000C$103.70C$4,459,272.00
7/17/2015Wayne Walter KreppnerInsiderSell4,800C$103.00C$494,400.00
7/3/2015Jordan KupinskyDirectorSell10,800C$92.21C$995,884.20
7/2/2015Jordan KupinskyDirectorSell45,900C$92.05C$4,224,934.35
6/26/2015Robert Steven AltmanInsiderSell62,500C$93.93C$5,870,893.75
6/22/2015John-Michel HussDirectorSell5,000C$92.00C$460,000.00
6/19/2015John-Michel HussDirectorSell4,300C$90.00C$387,000.00
6/11/2015John-Michel HussDirectorSell4,500C$90.02C$405,076.50
5/27/2015Saldanha Adrian DeInsiderBuy1,000C$80.61C$80,610.00
5/19/2015Adeel AhmadInsiderSell25,000C$83.80C$2,094,890.00
10/31/2014James Christopher ReebalsDirectorSell7,500C$37.25C$279,360.75
10/30/2014James Christopher ReebalsDirectorSell7,500C$37.06C$277,926.75
10/29/2014James Christopher ReebalsDirectorSell5,000C$37.07C$185,336.50
(Data available from 1/1/2013 forward)


Headline Trends for Concordia International Corp (TSE:CXR)
Latest Headlines for Concordia International Corp (TSE:CXR)
DateHeadline logoConcordia International Corp (CXR) Given Consensus Rating of "Sell" by Analysts - May 23 at 7:48 AM logoConcordia International Corp (CXR) Director Graeme Neville Duncan Sells 7,065 Shares - May 17 at 8:34 PM logoConcordia International Corp (CXR) PT Lowered to C$0.35 - May 12 at 1:02 PM logoEdited Transcript of CXR.TO earnings conference call or presentation 10-May-17 12:30pm GMT - May 10 at 9:49 PM logoConcordia International Corp. Announces Two New Appointments to ... - PR Newswire (press release) - May 4 at 8:02 AM logoConcordia International Corp. Announces Release Date for First Quarter 2017 Results - May 2 at 8:03 PM logoConcordia International Corp (CXR) Given Consensus Recommendation of "Sell" by Analysts - April 28 at 10:37 AM logoConcordia International Appoints David Price as Chief Financial Officer - April 27 at 1:48 AM logoCanadian Stocks Are Extending Recent Losses - Canadian Commentary - April 13 at 11:46 AM logoConcordia International Corp (CXR) Given Average Rating of "Sell" by Analysts - April 3 at 1:42 PM logoCanadian Stocks Are Paring Early Gains - Canadian Commentary - March 17 at 9:58 PM logoStocks Rally On Oil Rebound, Sober Fed -- Canadian Commentary - March 15 at 5:04 PM logoConcordia International Announces Fourth Quarter and Fiscal 2016 Results - March 15 at 9:47 AM logoQ4 2016 Concordia International Corp Earnings Release - Before Market Open - March 15 at 9:47 AM logoRedHill Biopharma's Co-Promotion Partner Concordia Announces ... - Nasdaq - March 7 at 4:34 PM logoConcordia International Corp. Grant of Treble Damages Further Vindicates Marketing Rights of its Donnatal® Brand - Yahoo Finance - March 7 at 4:34 PM logoProfile: Concordia International Corp (CXR.TO) - February 7 at 10:47 PM logoCanadian Stocks Are Extending Their Losses In Early Trade - Canadian Commentary - Nasdaq - January 31 at 5:15 PM logoConcordia International Corp. Announces Leadership Transition at International Segment - December 28 at 11:59 AM logoTSX Slightly Higher, Blackberry Makes Bet On Self-driving Cars - December 20 at 5:23 PM



Concordia International Corp (CXR) Chart for Thursday, May, 25, 2017

This page was last updated on 5/25/2017 by Staff